Table 1.
Number and geographical coverage of studies that had measured the prevalence of hepatitis B surface antigen (HBsAg) or antibodies to the hepatitis C virus (anti-HCV) in each population group by country: countries in the WHO European Region outside EU/EFTA
| (a) General population and blood donors | ||||||||
|---|---|---|---|---|---|---|---|---|
| Country | General population | Blood donors | ||||||
| HBsAg | Anti-HCV | HBsAg | Anti-HCV | |||||
| No. of studies | Coverage of studies | No. of studies | Coverage of studies | No. of studies | Coverage of studies | No. of studies | Coverage of studies | |
| Albania | 3 | National (x2), 1 city/area | 1 | 1 city/area | 2 | 1 city/area, n.s. | 2 | 1 city/area, n.s. |
| Armenia | 0 | 0 | 0 | 0 | ||||
| Azerbaijan | 0 | 0 | 0 | 0 | ||||
| Belarus | 0 | 0 | 0 | 0 | ||||
| Bosnia & Herzegovina | 0 | 0 | 1 | National | 2 | National, 1 city/area | ||
| Croatia | 0 | 0 | 1 | National | 1 | National | ||
| Georgia | 0 | 1 | 1 city/area | 0 | 0 | |||
| Israel | 0 | 0 | 1 | National | 1 | National | ||
| Kazakhstan | 1 | 1 city/area | 2 | National, 1 city/area | 1 | National | 0 | |
| Kyrgyzstan | 0 | 1 | 2 cities/areas | 0 | 0 | |||
| Montenegro | 0 | 0 | 1 | National | 1 | National | ||
| Republic of Moldova | 0 | 0 | 0 | 0 | ||||
| Russian Federation | 2 | ?National, 1 city/area | 2 | ?National, 1 city/area | 1 | 1 city/area | 1 | 1 city/area |
| Serbia (incl. Kosovo*) | 1 | 1 city/area | 1 | 1 city/area | 1 | 1 city/area | 1 | 1 city/area |
| Tajikistan | 0 | 1 | Multi-site | 1 | National | 1 | National | |
| The former Yugoslav Republic of Macedonia | 0 | 0 | 1 | 1 city/area | 1 | 1 city/area | ||
| Turkey | 9 | Multi-site (x2), 1 city/area (x7) | 7 | Multi-site, 1 city/area (x6) | 3 | National, 1 city/area (x2) | 3 | National, 1 city/area (x2) |
| Turkmenistan | 0 | 0 | 0 | 0 | ||||
| Ukraine | 4 | Unclear | 3 | Unclear | 3 | Unclear | 2 | Unclear |
| Uzbekistan | 1 | Multisite | 1 | Multisite | 1 | Multisite | 2 | Multisite |
| Total | 21 | 20 | 18 | 18 | ||||
| (b) People who injecting drugs (PWID) | ||||
|---|---|---|---|---|
| PWID | ||||
| HBsAg | Anti-HCV | |||
| No. ofstudies | Coverage of studies | No. of studies | Coverage of studies | |
| Albania | 1 | 1 city/area | 2 | 1 city/area |
| Armenia | 0 | 0 | ||
| Azerbaijan | 1 | Multi-site | 2 | Multi-site, 2 cities/areas |
| Belarus | 1 | Multi-site | 2 | Multi-site, 1 city/area |
| Bosnia & Herzegovina | 2 | Multi-site | 2 | Multi-site |
| Croatia | 3 | National multi-site, 1 city/area | 3 | National, multi-site, 1 city/area |
| Georgia | 3 | 1 city/area | 4 | Multi-site, 1 city/area (x3) |
| Israel | 1 | National | 1 | National |
| Kazakhstan | 1 | 2 cities/areas | 2 | National, 2 cities/areas |
| Kyrgyzstan | 0 | 2 | Multi-site, 2 cities/areas | |
| Montenegro | 1 | Unclear | 2 | 1 city/area, unclear |
| Republic of Moldova | 1 | National | 1 | National |
| Russian Federation | 2 | 2 cities/areas, 1 city/area | 16 | Multi-site (x2), 1 city/area (x12), unclear (x2) |
| Serbia (incl. Kosovo*) | 1 | 1 city/area | 3 | Multi-site, 1 city/area (x2) |
| Tajikistan | 0 | 2 | Multi-site, 1 city/area | |
| The former Yugoslav Republic of Macedonia | 0 | 0 | ||
| Turkey | 1 | Multi-site | 1 | 1 city/area |
| Turkmenistan | 0 | 0 | ||
| Ukraine | 3 | 1 city/area (x1), unclear (x2) | 6 | 1 city/area (x4), unclear (x2) |
| Uzbekistan | 0 | 2 | National multi-site | |
| Total | 22 | 53 | ||
| (c) Men who have sex with men (MSM) and sex workers | ||||||||
|---|---|---|---|---|---|---|---|---|
| MSM | Sex workers | |||||||
| HBsAg | Anti-HCV | HBsAg | Anti-HCV | |||||
| No. of studies | Coverage of studies | No. of studies | Coverage of studies | No. of studies | Coverage of studies | No. of studies | Coverage of studies | |
| Albania | 1 | 1 city/area | 0 | 0 | 0 | |||
| Armenia | 0 | 0 | 0 | 0 | ||||
| Azerbaijan | 1 | 1 city/area | 1 | 1 city/area | 1 | Multi-site | 1 | Multi-site |
| Belarus | 0 | 0 | 0 | 0 | ||||
| Bosnia & Herzegovina | 1 | National | 1 | National | 1 | National | 1 | National |
| Croatia | 1 | 1 city/area | 2 | 1 city/area, national | 0 | 1 | National | |
| Georgia | 1 | 1 city/area | 1 | 1 city/area | 0 | 0 | ||
| Israel | 0 | 0 | 0 | 0 | ||||
| Kazakhstan | 0 | 1 | National | 0 | 1 | National | ||
| Kyrgyzstan | 0 | 1 | National | 0 | 3 | National multi-site, 1 city/area | ||
| Montenegro | 0 | 0 | 0 | 0 | ||||
| Republic of Moldova | 0 | 1 | 1 city/area | 0 | 1 | 1 city/area | ||
| Russian Federation | 0 | 1 | 2 cities/areas | 0 | 3 | Multi-site, 1 city/area (x2) | ||
| Serbia (incl. Kosovo*) | 1 | 1 city/area | 1 | 1 city/area | 1 | 1 city/area | 1 | 1 city/area |
| Tajikistan | 0 | 0 | 0 | 1 | National | |||
| The former Yugoslav Republic of Macedonia | 0 | 0 | 0 | 0 | ||||
| Turkey | 1 | Multi-site | 0 | 2 | Multi-site, 1 city/area | 1 | 1 city/area | |
| Turkmenistan | 0 | 0 | 0 | 0 | ||||
| Ukraine | 1 | Unclear | 1 | Unclear | 1 | Unclear | 1 | Unclear |
| Uzbekistan | 0 | 0 | 0 | 2 | Multi-site, 1 city/area | |||
| Total | 8 | 11 | 6 | 17 | ||||
EU/EFTA, European Union and European Free Trade Association area; n.s., not stated.; ‘?’, preceding a detail indicates that the information available on this item in the source was limited.
*
According to United Nations Security Council Resolution 1244 (1999).